DLD Asset Management’s Aspire Biopharma Warrant ASBPW Stock Holding History

DLD Asset Management’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23,312	Closed	-$1.86K	–	141
2022 Q4	$1.86K	Buy	23,312 +1,687	+8%	+$113	﹤0.01%	143
2022 Q3	$2K	Hold	21,625	–	–	﹤0.01%	195
2022 Q2	$4K	Buy	+21,625	New	+$4.7K	﹤0.01%	215

Other funds holding ASBPW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Verition Fund Management

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return